These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 9887491)
41. Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS). Rothermundt C; Thurneysen C; Cathomas R; Müller B; Mingrone W; Hirschi-Blickenstorfer A; Wehrhahn T; Ruf C; Rothschild S; Seifert B; Terbuch A; Grassmugg T; Woelky R; Fankhauser C; Kunit T; Fischer N; Inauen R; Kamradt J; Ziegler K; Haynes A; Jüni P; Gillessen S Swiss Med Wkly; 2018; 148():w14640. PubMed ID: 30044478 [TBL] [Abstract][Full Text] [Related]
42. The Significance of Spermatic Cord Involvement by Testicular Germ Cell Tumors: Should We Be Staging Discontinuous Invasion From Involved Lymphovascular Spaces Differently From Direct Extension? Sanfrancesco JM; Trevino KE; Xu H; Ulbright TM; Idrees MT Am J Surg Pathol; 2018 Mar; 42(3):306-311. PubMed ID: 29309304 [TBL] [Abstract][Full Text] [Related]
43. [Follow-up of testicular germ cell cancer patients: interdisciplinary evidence-based recommendations]. Hartmann M; Krege S; Souchon R; De Santis M; Gillessen S; Cathomas R; Urologe A; 2011 Jul; 50(7):830-5. PubMed ID: 21503662 [TBL] [Abstract][Full Text] [Related]
44. Salvage chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) in relapsed or cisplatin-refractory germ cell tumors. Park S; Lee S; Lee J; Park SH; Park JO; Kang WK; Park YS; Lim HY Onkologie; 2011; 34(8-9):416-20. PubMed ID: 21934340 [TBL] [Abstract][Full Text] [Related]
45. Diagnosis and treatment of urological malignancy: the testes. Wilkins M; Horwich A Br J Hosp Med; 1996 Feb 21-Mar 5; 55(4):199-203. PubMed ID: 8777501 [TBL] [Abstract][Full Text] [Related]
46. Use of Risk Factors To Select Adjuvant Therapy Versus Surveillance for Testicular Nonseminoma and Seminoma Germ Cell Tumors. Daugaard G; Lauritsen J; Bandak M; Agerbæk M; Als AB; Dysager L; Toft BG; Engvad B; Berney DM; Wagner T Eur Urol Focus; 2024 May; 10(3):359-360. PubMed ID: 38871631 [TBL] [Abstract][Full Text] [Related]
47. Early outcomes and patterns of failure following proton therapy for nonmetastatic intracranial nongerminomatous germ cell tumors. Mokhtech M; Rotondo RL; Bradley JA; Sandler ES; Nanda R; Logie N; Aldana PR; Morris CG; Indelicato DJ Pediatr Blood Cancer; 2018 Jun; 65(6):e26997. PubMed ID: 29380526 [TBL] [Abstract][Full Text] [Related]
48. What is the role of enlarged lymph node resection alone in patients with nonseminomatous germ cell tumor who had stage II or III disease? Ekenel M; Keskin S; Sanli Ö; Bavbek S; Tunç M; Ander H; Ozcan F; Kiliçaslan I; Başaran M Clin Genitourin Cancer; 2012 Sep; 10(3):185-9. PubMed ID: 22682983 [TBL] [Abstract][Full Text] [Related]
49. [Therapy of germ cell tumors. Model for interdisciplinary treatment approach]. Schmoll HJ Med Klin (Munich); 1996 Apr; 91 Suppl 3():80-4. PubMed ID: 8692125 [No Abstract] [Full Text] [Related]
50. [Value of radiotherapy in interdisciplinary management of testicular germ cell tumors]. Classen J; Souchon R; Herrmann E; Bamberg M Urologe A; 2000 Mar; 39(2):126-32. PubMed ID: 10768222 [TBL] [Abstract][Full Text] [Related]
51. Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study. Wessalowski R; Schneider DT; Mils O; Friemann V; Kyrillopoulou O; Schaper J; Matuschek C; Rothe K; Leuschner I; Willers R; Schönberger S; Göbel U; Calaminus G; Lancet Oncol; 2013 Aug; 14(9):843-52. PubMed ID: 23823158 [TBL] [Abstract][Full Text] [Related]
52. Review of Discordance Between American Urological Association and European Association of Urology Guideline Recommendations for Testicular Cancer. Cazzaniga W; Pierorazio P; Heidenreich A Eur Urol Focus; 2024 May; 10(3):383-386. PubMed ID: 38849277 [TBL] [Abstract][Full Text] [Related]
54. Stage II seminomas and nonseminomas. Chung PW; Bedard P Hematol Oncol Clin North Am; 2011 Jun; 25(3):529-41,viii. PubMed ID: 21570607 [TBL] [Abstract][Full Text] [Related]
55. [Testicular Cancer: Diagnostics, Therapy and Follow Up]. Kälin M; Mauti L; Pless M Praxis (Bern 1994); 2016 May; 105(11):643-8. PubMed ID: 27223417 [TBL] [Abstract][Full Text] [Related]
56. [Management of testicular cancer]. Schneevoigt B; Stief CG; Karl A MMW Fortschr Med; 2013 Dec; 155(21-22):40-2. PubMed ID: 24724271 [No Abstract] [Full Text] [Related]
57. Post-chemotherapy retroperitoneal lymph node dissection in the management of metastatic testis cancer: the 16-year experience in an Irish setting. Considine S; Heaney R; Conroy R; Thornhill JA Ir J Med Sci; 2016 Nov; 185(4):901-907. PubMed ID: 26692387 [TBL] [Abstract][Full Text] [Related]
58. Management of Stage II testicular seminoma over a period of 40 years. Detti B; Livi L; Scoccianti S; Gacci M; Lapini A; Cai T; Meattini I; Mileo AM; Iannalfi A; Bruni A; Biti G Urol Oncol; 2009; 27(5):534-8. PubMed ID: 18848787 [TBL] [Abstract][Full Text] [Related]
59. Evolution and controversies in the management of low-stage nonseminomatous germ-cell tumors of the testis. Pizzocaro G; Nicolai N; Salvioni R World J Urol; 1994; 12(3):113-9. PubMed ID: 7524920 [TBL] [Abstract][Full Text] [Related]
60. Preservation of retroperitoneal lymph nodes in patients with locoregional nonseminomatous germ cell tumors: surveillance and primary chemotherapy. von Eschenbach AC; Swanson DA; Johnson DE; Wishnow KI; Stephenson RA; Babaian RJ Prog Clin Biol Res; 1991; 370():385-92. PubMed ID: 1718009 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]